Low Stimulation EZ-IVF
Low Stimulation EZ-IVF
SIRM-New York is now offering EZ-IVF®, a gentle, low-stimulation form of IVF that is available to ALL patients and offers the following advantages:
-
Low Cost
-
An Option for No Injections
-
Requires No Anesthesia
-
Higher Success Rates than IUI
-
Allows for Genetic Screening CGH/PGD
EZ-IVF is also known elsewhere as “minimal stimulation IVF.” The ovaries of a woman are minimally stimulated, using low doses of oral medications (like clomid or femara) or gonadotropins, follicle-stimulating hormone and luteinizing hormone, in order to encourage the growth of a small cohort of eggs (some women though will still be high producers even with this low stim, and thats fine). Once mature, the eggs are retrieved and fertilized in the lab, and the resulting embryos are transferred back into the woman’s uterus. Genetic screening of embryos is also possible before fresh day 5 transfer with CGH should one wish.
EZ-IVF is less expensive, primarily because you are using much less medication and we offer a discounted price as well. However, keep in mind that because you are producing fewer embryos, it is less likely that you will have excess embryos to freeze at the end of the cycle.
ALL patients interested in EZ-IVF can do it; we impose no cut-offs or limitations. It is best utilized though by women with very good ovarian reserve (who will produce a good number of eggs in response to even low amounts of stimulation) and women with very low ovarian reserve (who will produce a low egg number even with high stimulation in which case low stimulation makes the most sense). It is also a good alternative for women who wish to minimize cost as well as their exposure to needles, hormones, or anesthesia.
Call SIRM-New York to discuss whether this approach is suited to your situation:
Manhattan Office: 646-792-7476
Westchester Office: 914-696-7476
Related Posts
Staggered IVF is a new approach to IVF. It involves the use of CGH to identify chromosomally normal (“competent”) embryos/blastocysts for selective transfer, thereby markedly improving the efficiency of the entire process. It addresses three important issues: First, it significantly increases the success rate per embryo transferred and thereby allows fewer embryos to be transferred … Read more
For more than a quarter century, medical scientists have attempted to defy the biological clock by freezing a woman’s eggs to preserve her fertility. Until recently, almost all such efforts have yielded very poor results. This is why, since the birth of the 1st “frozen egg baby” in the mid 1980’s, fewer than 1500 such … Read more
In the early ’90s, we identified, quantified and published widely on the importance of the pattern and thickness of the uterine lining (endometrium) in determining outcome following in vitro fertilization (IVF). Women in whom the thickness of the endometrium had an abnormal ultrasound pattern and measured less than 9mm around the time of egg retrieval … Read more
Sher Institute Founder, Geoffrey Sher has long been a pioneer in the field and has, along with SIRM colleagues, introduced: 1982: First to recommend the exclusive use of gonadotropins to stimulate follicular development for IVF 1983: First to introduce Intrauterine Insemination (IUI) of washed sperm for treating certain forms of infertility. 1989: First to report … Read more
THE EVOLUTION OF CGH EGG AND EMBRYO TESTING AT SIRM Geoffrey Sher MD Three problems have restricted the growth of IVF in the U.S: 1) Cost of service and lack of insurance reimbursement, 2) Ignorance of the fact that IVF is far more efficacious than other infertility treatment and, 3) OB-Gyn’s and/or Reproductive Endocrinologists (RE’s) that … Read more
The introduction of Vitrification combined with CGH technology has opened up new possibilities for IVF treatment and fertility preservation. One dilemma that women face when considering IVF at a later age is the fact that they generally have fewer eggs available, and of those, a higher percentage are chromosomally abnormal. A new option that has … Read more
Most methods of determining which embryo to transfer to the uterus during In Vitro Fertilization rely on a visual assessment under the microscope. The prettiest embryo wins. Unfortunately, this approach ignores the most common cause of IVF failure – chromosomal abnormalities. Doctors can’t tell by simply looking at an embryo whether it is chromosomally “competent.” … Read more
Ask Our DoctorsA Question
